Health
ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting
SUZHOU, China, and ROCKVILLE, Md., Nov. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from multiple clinical studies of the ...
FWD Group announces robust growth momentum in new business highlights
HONG KONG, Nov. 3, 2023 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced new business highlights[1] for the nine months ended 30 September 2023. New business sales grew 22 percent[2] to US$1,253 million. Value of new business increased toUS$724 million, ...
The Sixth CIIE is ready to welcome the world
SHANGHAI, Nov. 3, 2023 /PRNewswire/ -- A total of 154 countries, regions and
international organizations have confirmed their participation in the sixth
edition of China International Import Expo (CIIE), which will take place from
Nov 5 to 10 in Shanghai.
PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients.
* Melbourne ophthalmology company PolyActiva is developing a unique biodegradable ocular implant that provides 6 months of sustained drug delivery for patients with glaucoma, the second most common cause of irreversible blindness. * The interim Phase 2a results demonstrate a sustained >20% re...
uLab® Announces Smart Outcomes™ for a Smart Office™--The Power and Flexibility of One Platform for Clear Aligners and Retainers
MEMPHIS, Tenn., Nov. 3, 2023 /PRNewswire/ -- uLab Systems™ announces Smart Outcomes for a Smart Office, one powerful, flexible platform designed exclusively for orthodontists, providing them with the ultimate cost-effective tool to easily create bespoke aligner treatments for each patient. The ab...
Frost & Sullivan Honors Komodo Health with Technology Innovation Leadership Award for Its Data-Driven Platform to Improve Patient Care
Komodo Health Delivers In-Depth and Actionable Patient-Level Insights for Enterprise Customers with its Robust Real-world Data, Advanced Analytics and AI-powered Algorithms, and Clinical and Industry Expertise SAN ANTONIO and SAN FRANCISCO, Nov. 2, 2023 /PRNewswire/ -- Frost & Sullivan recently ...
Complete Genomics and Basepair™ Announce Technology Integration Partnership
SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics' DNBSEQTM sequencing platforms*. The partnership gives ...
Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore
SINGAPORE, Nov. 2, 2023 /PRNewswire/ -- At the annual Singapore Week of Innovation and Technology (SWITCH) 2023, Lion TCR, a clinical-stage mRNA-based T cell immunotherapy company, is thrilled to announce a significant milestoneof clinching the T-Up Excellence Awards. This award, in recognitio...
CPIC: Harvesting Success in Insurance Services for the Greater Bay Area, Successful Hosting of the 2023 Greater Bay Area Customer Festival Press Conference
HONG KONG, Nov. 2, 2023 /PRNewswire/ -- China Pacific Insurance (Group) Co., Ltd. ("CPIC" or the "Company", Stock Code: 02601) is pleased to announce that the 2023 CPIC Greater Bay Area Customer Festival Press Conference was held in Guangzhou on the afternoon of October 31 with great success, a...
Ivonescimab's Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023
Potential First-in-Class Tetravalent Bispecific Antibody Demonstrates Enhanced Binding inthe Simultaneous Presence of PD-1 & VEGF Cooperative Binding of Ivonescimab Enables Higher Avidity in the Tumor Microenvironmentwith Over 18 Fold Increased Binding Affinity to PD-1 in the Presence of VEGF in...
Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
* FDA granted Breakthrough Therapy Designation for felzartamab in PMN upon positive clinical data from M-PLACE, a Phase 2 study led by I-Mab partner HI-Bio * I-Mab has full development and commercialization rights of felzartamab in Greater China for all indications, with Phase 3 multiple myelom...
Boryung Successfully Concludes 'Humans In Space Symposium' at 2023 ASCEND in Las Vegas
* HIS Symposium co-located with ASCEND, the world's event designed to accelerate the building of our sustainable off-world future, fromOctober 23 to 25. * Jay Kim, the Chairman and CEO of Boryung, invited as a speaker for ASCEND's opening and closing ceremonies and the panel discussion. * B...
FWD Insurance unveils its new "Celebrate Easy. Celebrate Living" brand campaign
Launches two new regular premium investment-linked products, FWD WealthLink and FWD Wealthlink Pro KUALA LUMPUR, Malaysia, Nov. 2, 2023 /PRNewswire/ -- FWD Insurance Berhad ("FWD Insurance") has unveiled its new brand campaign, "Celebrate Easy. Celebrate Living". Inspired by the company's visi...
European Medicines Agency validates Pierre Fabre Laboratories' marketing authorisation application for combination BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for patients with BRAFV600-mutant advanced non-small cell lung cancer (NSCLC)
- BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) shows meaningful clinical benefit in adult patients with BRAFV600-mutant advanced NSCLC - The application is based on results from the PHAROS study,[1] which showed an objective response rate of 75% in treatment-naïve patients and 46% in previou...
Cambrex Announces Sale of Drug Product Business Unit
EAST RUTHERFORD, N.J., Nov. 2, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), has today completed the sale of its Drug Product Business Unit toWilmington, Delaware based Noramco. Cambrex's Drug Product business provides product developme...
Chipscreen's New Drug Candidate CS32582 Capsules Approved for Clinical Treatment of Psoriasis
SHENZHEN, China, Nov. 2, 2023 /PRNewswire/ -- On Oct. 31, 2023, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen" and with stock code 688321.SH) received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration ("NMPA") thro...
Xinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi
BEIJING, Nov. 2, 2023 /PRNewswire/ -- The 54th Zhangshu National Traditional
Chinese Materia Medica Trade Fair was held recently in Zhangshu, a county-level
city in eastChina's Jiangxi Province.
Myrkl - The NEW Liver Function and Detox Support Supplement that sold out in 24hrs
Enjoy socialising without sacrificing the next day! AUCKLAND, New Zealand, Nov. 2, 2023 /PRNewswire/ -- Myrkl (pronounced myr-a-kle)is the new liver function and detox support supplement that is taking the world by storm. This innovative supplement contains patented AB001™ which activates i...
Fonterra shares New Zealand's best farming practices to upskill Thai dairy farmers
PAK CHONG, Thailand, Nov. 2, 2023 /PRNewswire/ -- New Zealand's largest dairy co-operative, Fonterra joined hands today with the Thai government to help upskill Thai dairy farmers and improve local farming practices. The 3-day dairy development program currently underway at the Nakornratchashima...
Chula Launches the Latest Parkinson's Gloves to Reduce Tremors
BANGKOK, Nov. 2, 2023 /PRNewswire/ -- Chula
Week's Top Stories
Most Reposted
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 319 media titles]
2024-05-08 14:37Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 310 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 297 media titles]
2024-05-08 16:44Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 285 media titles]
2024-05-09 11:00